基本信息
views: 133
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
My research topics:
1. Immune checkpoints and immunotherapy in tumors: Focus on the PD-1/PD-L1, CD73/A2aR, TIM3, CD58, OX40 and other novel immune checkpoints.
2. Tumor microenvironment and molecular classifications: Focus on the study of disorders of immune microenvironment caused by genetic and epigenetic modifications (including m6A), and immune-related classifications (including transcriptional and mutational signatures) in lymphoma.
3. Focus on illustrating the resistance genes and mechanisms of novel targeted drugs (including XPO1 inhibitor, p53 inhibitor, PIM1 inhibitor), and dynamic detection (including ctDNA) in lymphoma.
Research Interests
Papers共 152 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yue Fei,Xiaoyan Zhang, Xiaohui Wang, Yifei Sun,Jin He,Xia Liu,Zheng Song,Lanfang Li,Lihua Qiu,Zhengzi Qian,Shiyong Zhou,Xianming Liu,
Journal of Natural Medicinesno. 2 (2024): 285-295
Jiangfang Feng,Yue Fei, Meng Gao,Xiangrui Meng,Dongfeng Zeng, Dehui Zou,Haige Ye,Yun Liang,Xiuhua Sun,Rong Liang,Hui Zhou,Xianhuo Wang,
Xiyue Xu,Yidan Zhang,Yaxiao Lu, Xiaoyan Zhang,Cuicui Zhao, Jiesong Wang,Qingpei Guan,Yingfang Feng, Meng Gao,Jingwei Yu,Zheng Song,Xia Liu,
Cancer research (2024)
Hematological oncologyno. 4 (2024): e3279-e3279
Weicheng Ren,Hui Wan,Sulaf Abd Own,Mattias Berglund,Xianhuo Wang, Mingyu Yang, Xiaobo Li,Dongbing Liu,Xiaofei Ye,Kristina Sonnevi,Gunilla Enblad,Rose-Marie Amini,
Leukemiano. 3 (2024): 610-620
Junlei Jia, Xiaohui Wang,Zheng Song,Shen Meng,Yue Fei,Jingwei Yu,Xia Liu, Xue Han,Lanfang Li,Lihua Qiu,Zhengzi Qian,Shiyong Zhou,
CANCER BIOLOGY & MEDICINEno. 3 (2024): 223-229
crossref(2024)
Hematological Oncologyno. S2 (2023): 794-795
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn